Canadian Cancer Trials Group Bulletins

Trial Management Group

New Phase III Study Coordinators at CCTG

CCTG is pleased to welcome two new Phase III Study Coordinators to our team.

Roger Leung has an undergraduate degree in Cell and Molecular Biology from U of T and an MSc in Epidemiology from Queen's. He is coming to us from the Clinical Evaluation Research Unit at Queen's where he has been working as a clinical research project leader and clinical study monitor. He will be joining CCTG in mid June

Dora Baczyk holds an undergraduate degree in Biotechnology and an MSc in Physiology (U of T) and has been most recently employed as a Scientific Associate at the Lunenfeld-Tanenbaum Research Institute. She will be re-locating to Kingston and will join CCTG in mid July.

Please note that we are continuing to recruit Study Coordinators for the Group - the competition will remain open until positions are filled. The posting can be found on the Queen's website and the CCTG website